StreetAlpha.app
Home › Stocks › CVRX

CVRx, Inc. (CVRX)

Healthcare
$0.62
▲ +1.03%
LAST CLOSE · NOV 17

CVRx makes Barostim, an implantable device that uses electrical pulses to treat heart failure. It last closed at $0.62 on Nov 17, up 1.03% on the day. CVRX reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 3 analysts is $1.83 (+196.0% from the last close), with a high of $2.00 and a low of $1.50. Analyst consensus is Hold, based on the latest ratings from 3 firms (1 buy, 2 hold, 0 sell).

AI Auto Pilots
Is CVRX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$60.3M
+7.8% vs a year ago
Net income
−$53.3M
−88.3% margin
EPS (diluted)
−$2.00
Free cash flow
−$42.0M
−69.7% margin
Valuation
Market cap
$17.6M
28.5M shares
P/E
–
No P/E while losing money
Price to sales
0.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$58.7M
At Sep 30
Debt
$58.7M
At Sep 30
Shareholder equity
$13.8M
Shares outstanding
28.5M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $13.0M$13.0MFY2021FY2022: $22.5M$22.5MFY2022FY2023: $39.3M$39.3MFY2023FY2024: $51.3M$51.3MFY2024FY2025: $56.7M$56.7MFY2025

From CVRX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
-$0.51
$12.1M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
3firms
1 Buy2 Hold0 Sell
Each firm's latest rating on CVRX in the past 90 days
Average 12-month target
$1.83
▲ 196.0% upside

Based on 3 analysts who set a price target on CVRX in the past 90 days. The average target is $1.83, with a high of $2.00 and a low of $1.50, compared with the last close of $0.62.

Low $1.50Avg $1.83High $2.00
Blue marker: last close $0.62
Highest target$2.00
Average target$1.83
Lowest target$1.50
Latest rating changes
Cantor FitzgeraldTarget lowered
Nov 16Buy$5 → $2
Lake StreetTarget lowered
Nov 7Hold$3.50 → $1.50
Canaccord GenuityDowngrade
Nov 6Hold$2
Cantor FitzgeraldMaintained
Aug 17Buy$5
Lake StreetDowngrade
Aug 8Hold$3.50
DateFirmActionRatingPrice target
Nov 16Cantor FitzgeraldTarget loweredBuy$5 → $2
Nov 7Lake StreetTarget loweredHold$3.50 → $1.50
Nov 6Canaccord GenuityDowngradeHold$2
Aug 17Cantor FitzgeraldMaintainedBuy$5
Aug 8Lake StreetDowngradeHold$3.50
Loading…

Technical Analysis

CVRX · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 82% below its 20 day and 183% below its 50 day average. It is 698% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the 52 week low at $0.57, and the nearest resistance the Pivot at $0.62.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 24.9%/day
Key levels
$10.2852 week high+1558.1%
$4.94200 day average+696.8%
$3.00100 day average+383.9%
$1.7550 day average+182.3%
$1.49Swing high (Oct 27)+140.3%
$1.1320 day average+82.3%
$0.67Pivot R1+8.1%
$0.62Pivot+0.0%
$0.62Last close
$0.5752 week low−8.1%
$0.57Pivot S1−8.1%
Indicators
RSI (14)21.60Oversold below 30Oversold
MACD-0.32Below its signal lineBearish
Stochastic3.3Near the bottom of its rangeOversold
ADX (14)49.6Strong downtrend
Williams %R-94.9Oversold below −80, overbought above −20Oversold
CCI (20)-102.2Oversold below −100, overbought above 100Oversold
Rate of change−55.1%Change over 10 sessionsBearish
ATR (14)$0.15Typical daily range, 24.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CVRX

What happened before

See how CVRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow CVRX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CVRX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in CVRX in the last 90 days.

Loading…

See today’s whale options flow across the market →

CVRX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲47 buying vs 40 selling
  • ▼Held by funds -3.5 pts
  • ▼Funds holding -1
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding8788−1.1%
In funds' top 10110.0%
Held by funds54.5%58.0%−3.5 pts
New / increased16 / 319 / 35+6.8%
Reduced / sold out23 / 1727 / 18−11.1%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CVRX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CVRX is in one of them and how their past CVRX trades turned out.

CVRX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CVRX in an article yet. Here's the latest on the wider market.

CVRX Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Aug 26
Who traded CVRX · since 2026
Latest 1 filing
$1K – $15KTraded Jul 8, 2026Filed Aug 26, 2026
PersonTypeAmountTradedFiledDelay
Richard BlumenthalD · CTSell$1K – $15KJul 8, 2026Aug 26, 202649 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About CVRx

CVRx makes Barostim, an implantable device that delivers electrical pulses to sensors in the wall of the carotid artery to treat heart failure with reduced ejection fraction. The device is placed in a minimally invasive outpatient procedure and is designed to work alongside standard medications. Its customers include patients with this form of heart failure, the doctors who treat them, and the healthcare payers who cover the therapy. The company is based in Minneapolis, Minnesota.

Headquarters
Minneapolis, MN
Founded
2001